(Q44571334)

4 December 2017

Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections (English)

1 reference

4 December 2017

Pseudomonas aeruginosa

1 reference

F Follath

1

1 reference

4 December 2017

M Bindschedler

2

1 reference

4 December 2017

M Wenk

3

1 reference

4 December 2017

R Frei

4

1 reference

4 December 2017

H Stalder

5

1 reference

4 December 2017

H Reber

6

1 reference

4 December 2017

1 April 1986

1 reference

European journal of clinical microbiology

4 December 2017

1 reference

4 December 2017

5

1 reference

4 December 2017

236-240

1 reference

4 December 2017

2

1 reference

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

4 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Pharmacokinetics and tissue penetration of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013997

Multiple-dose ciprofloxacin kinetics in normal subjects

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2941289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2941289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2941289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF02013997

1 reference

4 December 2017

1 reference